Mesenchymal stromal cells for the prophylaxis and treatment of graft-versus-host disease—a meta-analysis

BACKGROUND: Graft-versus-host disease (GvHD) is the main life-threatening complication of allogeneic hematopoietic stem cell transplantation (HSCT). Thirty to 80% of GvHD patients do not respond to first-line treatment and a second-line treatment is not universally established. Based on their immuno...

Descripción completa

Detalles Bibliográficos
Autores principales: Morata-Tarifa, Cynthia, Macías-Sánchez, María del Mar, Gutiérrez-Pizarraya, Antonio, Sanchez-Pernaute, Rosario
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7027118/
https://www.ncbi.nlm.nih.gov/pubmed/32070420
http://dx.doi.org/10.1186/s13287-020-01592-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7027118/
https://www.ncbi.nlm.nih.gov/pubmed/32070420
http://dx.doi.org/10.1186/s13287-020-01592-z

Ejemplares similares